NASDAQ
Financial data for MRNA
53.29% YoY
24.46% YoY
24.88% YoY
Annual Income Statement for MRNA
| Item | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | $3B | $7B | $19B | $18B | $803M |
| Cost of Revenue | $1B | $5B | $5B | $3B | $39M |
| Gross Profit | $2B | $2B | $13B | $15B | $764M |
| Operating Expenses | $6B | $6B | $4B | $2B | $2B |
| Operating Income | -$4B | -$4B | $9B | $13B | -$763M |
| Net Income | -$4B | -$5B | $8B | $12B | -$747M |
| EPS | $-9.27 | $-12.34 | $21.26 | $30.31 | $-1.96 |
| EBITDA | -$3B | -$3B | $10B | $14B | -$703M |
No price data available for this timeframe.